Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 92

1.

Pharmacophore-based discovery of new human dihydroorotate dehydrogenase inhibitor.

Lu P, Wang Y, Ma B, She J, Zhang Q, He M, Liu Y.

Med Chem. 2014 Jun;10(4):402-8.

PMID:
24047257
[PubMed - in process]
2.

Potent BACE-1 inhibitor design using pharmacophore modeling, in silico screening and molecular docking studies.

John S, Thangapandian S, Sakkiah S, Lee KW.

BMC Bioinformatics. 2011 Feb 15;12 Suppl 1:S28. doi: 10.1186/1471-2105-12-S1-S28.

PMID:
21342558
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

A specific pharmacophore model of sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors.

Tang C, Zhu X, Huang D, Zan X, Yang B, Li Y, Du X, Qian H, Huang W.

J Mol Model. 2012 Jun;18(6):2795-804. doi: 10.1007/s00894-011-1303-1. Epub 2011 Nov 27.

PMID:
22120948
[PubMed - indexed for MEDLINE]
4.

Development, evaluation and application of 3D QSAR Pharmacophore model in the discovery of potential human renin inhibitors.

John S, Thangapandian S, Arooj M, Hong JC, Kim KD, Lee KW.

BMC Bioinformatics. 2011 Dec 14;12 Suppl 14:S4. doi: 10.1186/1471-2105-12-S14-S4.

PMID:
22372967
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Three-dimensional quantitative structure-activity relationship analysis of a set of Plasmodium falciparum dihydrofolate reductase inhibitors using a pharmacophore generation approach.

Parenti MD, Pacchioni S, Ferrari AM, Rastelli G.

J Med Chem. 2004 Aug 12;47(17):4258-67.

PMID:
15293997
[PubMed - indexed for MEDLINE]
6.

A three-dimensional pharmacophore model for IMPDH inhibitors.

Yang N, Wang J, Li J, Wang QH, Wang Y, Cheng MS.

Chem Biol Drug Des. 2011 Jul;78(1):175-82. doi: 10.1111/j.1747-0285.2011.01128.x. Epub 2011 May 31.

PMID:
21507206
[PubMed - indexed for MEDLINE]
7.

3D QSAR pharmacophore modeling for c-Met kinase inhibitors.

Huang D, Zhu X, Tang C, Mei Y, Chen W, Yang B, Han J, Qian H, Huang W.

Med Chem. 2012 Nov;8(6):1117-25.

PMID:
22779800
[PubMed - indexed for MEDLINE]
8.

3D QSAR pharmacophore based virtual screening and molecular docking for identification of potential HSP90 inhibitors.

Sakkiah S, Thangapandian S, John S, Kwon YJ, Lee KW.

Eur J Med Chem. 2010 Jun;45(6):2132-40. doi: 10.1016/j.ejmech.2010.01.016. Epub 2010 Feb 4.

PMID:
20206418
[PubMed - indexed for MEDLINE]
9.

Pharmacophore modeling for protein tyrosine phosphatase 1B inhibitors.

Bharatham K, Bharatham N, Lee KW.

Arch Pharm Res. 2007 May;30(5):533-42.

PMID:
17615669
[PubMed - indexed for MEDLINE]
10.

The first pharmacophore model for potent G protein-coupled receptor 119 agonist.

Zhu X, Huang D, Lan X, Tang C, Zhu Y, Han J, Huang W, Qian H.

Eur J Med Chem. 2011 Jul;46(7):2901-7. doi: 10.1016/j.ejmech.2011.04.014. Epub 2011 Apr 13.

PMID:
21524831
[PubMed - in process]
11.

Pharmacophore mapping of arylamino-substituted benzo[b]thiophenes as free radical scavengers.

Mitra I, Saha A, Roy K.

J Mol Model. 2010 Oct;16(10):1585-96. doi: 10.1007/s00894-010-0661-4. Epub 2010 Mar 1.

PMID:
20195668
[PubMed - indexed for MEDLINE]
12.

Pharmacophore modeling and virtual screening to identify potential RET kinase inhibitors.

Shih KC, Shiau CW, Chen TS, Ko CH, Lin CL, Lin CY, Hwang CS, Tang CY, Chen WR, Huang JW.

Bioorg Med Chem Lett. 2011 Aug 1;21(15):4490-7. doi: 10.1016/j.bmcl.2011.06.003. Epub 2011 Jun 12.

PMID:
21724393
[PubMed - indexed for MEDLINE]
13.

Discovery of novel acyl coenzyme a: cholesterol acyltransferase inhibitors: pharmacophore-based virtual screening, synthesis and pharmacology.

Chhabria MT, Brahmkshatriya PS, Mahajan BM, Darji UB, Shah GB.

Chem Biol Drug Des. 2012 Jul;80(1):106-13. doi: 10.1111/j.1747-0285.2012.01384.x. Epub 2012 Apr 27.

PMID:
22429570
[PubMed - indexed for MEDLINE]
14.
15.

Pharmacophore mapping of diverse classes of farnesyltransferase inhibitors.

Equbal T, Silakari O, Rambabu G, Ravikumar M.

Bioorg Med Chem Lett. 2007 Mar 15;17(6):1594-600. Epub 2007 Jan 4.

PMID:
17236767
[PubMed - indexed for MEDLINE]
16.

3D-pharmacophore models for selective A2A and A2B adenosine receptor antagonists.

Wei J, Wang S, Gao S, Dai X, Gao Q.

J Chem Inf Model. 2007 Mar-Apr;47(2):613-25. Epub 2007 Mar 2.

PMID:
17330954
[PubMed - indexed for MEDLINE]
17.

Pharmacophore filtering and 3D-QSAR in the discovery of new JAK2 inhibitors.

Dhanachandra Singh Kh, Karthikeyan M, Kirubakaran P, Nagamani S.

J Mol Graph Model. 2011 Sep;30:186-97. doi: 10.1016/j.jmgm.2011.07.004. Epub 2011 Jul 22.

PMID:
21831680
[PubMed - indexed for MEDLINE]
18.
19.

Pharmacophore-based virtual screening and docking studies on Hsp90 inhibitors.

Saxena S, Chaudhaery SS, Varshney K, Saxena AK.

SAR QSAR Environ Res. 2010 Jul;21(5-6):445-62. doi: 10.1080/1062936X.2010.501817.

PMID:
20818581
[PubMed - indexed for MEDLINE]
20.

3D QSAR pharmacophore model based on diverse IKK╬▓ inhibitors.

Nagarajan S, Ahmed A, Choo H, Cho YS, Oh KS, Lee BH, Shin KJ, Pae AN.

J Mol Model. 2011 Feb;17(2):209-18. doi: 10.1007/s00894-010-0714-8. Epub 2010 Apr 25.

PMID:
20419497
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk